Eris Lifesciences Q1 FY27 Results: Net Profit ₹143.3 Cr, Up 14.5% YoY
Eris Lifesciences Ltd reported revenue from operations of ₹873.2 Cr (+13.0% YoY) and net profit of ₹143.3 Cr (+14.5% YoY) for Q1 FY27.
- Key figure
- Net profit ₹143.3 Cr · +14.5% YoY
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Eris Lifesciences Ltd reported revenue from operations of ₹873.2 Cr (+13.0% YoY) and net profit of ₹143.3 Cr (+14.5% YoY) for Q1 FY27.
Eris Lifesciences Ltd reported revenue from operations of ₹756.6 Cr (+7.3% YoY) and net profit of ₹279.1 Cr (+172.8% YoY) for Q4 FY26.
Eris Lifesciences reported audited FY26 results and declared an interim dividend of Rs. 7.21 per share. The company recorded consolidated annual net profit of ₹647.51 Crore.
Eris Lifesciences Ltd reported net profit of ₹109 Cr (+25.1% YoY) for Q3 FY26.